SUPERNUS PHARMACEUTICALS, INC. financial data

Symbol
SUPN on Nasdaq
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 227% % 21%
Quick Ratio 21% % -9.4%
Debt-to-equity 32% % -14%
Return On Equity -1.8% % -129%
Return On Assets -1.4% % -130%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57,339,350 shares 3.8%
Common Stock, Shares, Outstanding 57,119,153 shares 3.4%
Entity Public Float $1,413,025,683 USD
Common Stock, Value, Issued $57,000 USD 3.6%
Weighted Average Number of Shares Outstanding, Basic 56,552,741 shares 2.5%
Weighted Average Number of Shares Outstanding, Diluted 56,552,741 shares 0.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $681,539,000 USD 4.5%
Research and Development Expense $107,055,000 USD 3.4%
Costs and Expenses $718,480,000 USD 21%
Operating Income (Loss) $36,941,000 USD -162%
Nonoperating Income (Expense) $16,207,000 USD 23%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $20,734,000 USD -129%
Income Tax Expense (Benefit) $1,617,000 USD -113%
Net Income (Loss) Attributable to Parent $19,117,000 USD -132%
Earnings Per Share, Basic 0 USD/shares -131%
Earnings Per Share, Diluted 0 USD/shares -131%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $151,371,000 USD 378%
Accounts Receivable, after Allowance for Credit Loss, Current $171,254,000 USD 18%
Inventory, Net $107,100,000 USD 67%
Assets, Current $593,891,000 USD -7.2%
Deferred Income Tax Assets, Net $8,793,000 USD
Property, Plant and Equipment, Net $10,627,000 USD -11%
Operating Lease, Right-of-Use Asset $28,761,000 USD 10%
Intangible Assets, Net (Excluding Goodwill) $623,481,000 USD 15%
Goodwill $119,080,000 USD 1.8%
Other Assets, Noncurrent $62,432,000 USD 86%
Assets $1,419,754,000 USD 5.7%
Accounts Payable, Current $8,177,000 USD 28%
Employee-related Liabilities, Current $35,297,000 USD 74%
Accrued Liabilities, Current $108,613,000 USD 43%
Liabilities, Current $330,629,000 USD 13%
Deferred Income Tax Liabilities, Net $0 USD -100%
Operating Lease, Liability, Noncurrent $31,422,000 USD 8.6%
Other Liabilities, Noncurrent $7,823,000 USD 6.4%
Liabilities $370,087,000 USD 10%
Accumulated Other Comprehensive Income (Loss), Net of Tax $71,000 USD -191%
Retained Earnings (Accumulated Deficit) $521,981,000 USD -3.5%
Stockholders' Equity Attributable to Parent $1,049,667,000 USD 4.2%
Liabilities and Equity $1,419,754,000 USD 5.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $30,599,000 USD -20%
Net Cash Provided by (Used in) Financing Activities $21,399,000 USD -1463%
Net Cash Provided by (Used in) Investing Activities $37,317,000 USD
Common Stock, Shares Authorized 130,000,000 shares 0%
Common Stock, Shares, Issued 57,119,153 shares 3.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $46,517,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $152,821,000 USD 382%
Deferred Tax Assets, Valuation Allowance $66,725,000 USD 9.6%
Deferred Tax Assets, Gross $199,459,000 USD 3.8%
Operating Lease, Liability $42,212,000 USD 11%
Payments to Acquire Property, Plant, and Equipment $327,000 USD 32%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $19,266,000 USD -132%
Lessee, Operating Lease, Liability, to be Paid $39,997,000 USD
Property, Plant and Equipment, Gross $30,087,000 USD 3.3%
Operating Lease, Liability, Current $10,790,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,957,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $8,234,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) $3,990,000 USD 27%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,726,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,735,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $93,109,000 USD -8.1%
Unrecognized Tax Benefits $5,840,000 USD 172%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,004,000 USD
Operating Lease, Payments $3,892,000 USD -2.7%
Additional Paid in Capital $527,700,000 USD 13%
Amortization of Intangible Assets $83,174,000 USD 2.9%
Depreciation, Depletion and Amortization $20,383,000 USD -1.8%
Deferred Tax Assets, Net of Valuation Allowance $132,734,000 USD 1.1%
Share-based Payment Arrangement, Expense $53,952,000 USD 103%
Interest Expense $0 USD -100%